Your browser doesn't support javascript.
loading
Cefiderocol for the Treatment of Infections Due to Metallo-B-lactamase-Producing Pathogens in the CREDIBLE-CR and APEKS-NP Phase 3 Randomized Studies.
Timsit, Jean Francois; Paul, Mical; Shields, Ryan K; Echols, Roger; Baba, Takamichi; Yamano, Yoshinori; Portsmouth, Simon.
Afiliação
  • Timsit JF; Infection, Antimicrobials, Modelling, Evolution Research Center, Université de Paris (Paris-Diderot), UMR 1137, Paris, France.
  • Paul M; Medical and Infectious Diseases Intensive Care Unit, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Bichat, Paris, France.
  • Shields RK; Division of Infectious Diseases, Rambam Health Care Campus, and Technion Israel Institute of Technology Ruth and Bruce Rappaport Faculty of Medicine, Haifa, Israel.
  • Echols R; Division of Infectious Diseases, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Baba T; Infectious Disease Drug Development Consulting, LLC, Easton, Connecticut, USA.
  • Yamano Y; Shionogi & Co, Ltd, Osaka, Japan.
  • Portsmouth S; Shionogi & Co, Ltd, Osaka, Japan.
Clin Infect Dis ; 75(6): 1081-1084, 2022 09 29.
Article em En | MEDLINE | ID: mdl-35148378
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cefalosporinas / Antibacterianos Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cefalosporinas / Antibacterianos Idioma: En Ano de publicação: 2022 Tipo de documento: Article